CAS 15721-05-8
:2,2,4,4,6,6,8-Heptametilciclotetrasiloxano
- 1,3,3,5,5,7,7-Heptamethylcyclotetrasiloxane
- 2,2,4,4,6,6,8-Heptamethyl-1,3,5,7,2,4,6,8-Tetroxatetrasilocane
- 2,2,4,4,6,6,8-Heptamethyl-1,3,5,7,2,4,6,8-tetraoxatetrasilocane
- 2,2,4,4,6,6,8-Heptamethylcyclotetrasiloxane
- 2,4,4,6,6,8,8-Heptamethyl-1,3,5,7,2,4,6,8-Tetroxatetrasilocan-2-Yl
- Cyclotetrasiloxane, 2,2,4,4,6,6,8-heptamethyl-
- Cyclotetrasiloxane, heptamethyl-
- Heptamethyl-Cyclotetrasiloxan
- Heptamethylcyclotetrasiloxane
Heptamethylcyclotetrasiloxane
CAS:Applications Heptamethylcyclotetrasiloxane is used in the study of the structure-activity relations of organosiloxanes and the female reproductive system.
References Hayden, J. F., et al.: Toxicol. Appl. Pharmacol., 21, 68 (1972)Fórmula:C7H22O4Si4Cor e Forma:NeatPeso molecular:282.59Heptamethyl cyclotetrasiloxane
CAS:S09240 - Heptamethyl cyclotetrasiloxane
Fórmula:C7H22O4Si4Pureza:90%Cor e Forma:ClearPeso molecular:282.589Heptamethylcyclotetrasiloxane
CAS:Heptamethylcyclotetrasiloxane is a medicinal compound that has been found to have anticancer properties. It acts as an inhibitor of kinases, which are proteins that play a key role in cancer cell growth and proliferation. Heptamethylcyclotetrasiloxane has been shown to induce apoptosis (programmed cell death) in cancer cells, making it a potential treatment for various types of tumors. This compound is an analog of other kinase inhibitors and has been tested in both Chinese and human cancer cell lines with promising results. Its ability to inhibit kinases makes it a potential candidate for further development as an anticancer drug.
Fórmula:C7H21O4Si4Pureza:Min. 95%Peso molecular:281.58 g/mol





